Search

Author/Creator Hoffman, Deborah

3. Evaluation of what matters most in existing clinical outcomes assessments in Alzheimer's disease: Neuropsychiatry and behavioral neurology/treatment development and clinical trials. (7th December 2020)

Authors:
Hartry, Ann; Menne, Heather; Wronski, Samantha L.; Paulsen, Russ; Callahan, Leigh F.; Potashman, Michele; Lee, Daniel; Wunderlich, Glen; Hoffman, Deborah; Wieberg, Dan; Kremer, Ian N.; Hauber, Brett; DiBenedetti, Dana B.
Journal:
Alzheimer's & dementia
Issue:
Volume 16(2020)Supplement 6
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Quantifying what matters most to patients and care partners in Alzheimer's disease: Neuropsychiatry and behavioral neurology/treatment development and clinical trials. (7th December 2020)

Authors:
Hauber, Brett; Paulsen, Russ; Callahan, Leigh F.; Potashman, Michele; Lee, Daniel; Hartry, Ann; Wunderlich, Glen; Hoffman, Deborah; Wieberg, Dan; Kremer, Ian N.; DiBenedetti, Dana B.
Journal:
Alzheimer's & dementia
Issue:
Volume 16(2020)Supplement 6
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The importance of care partner input in Alzheimer's disease (AD) drug development: Neuropsychiatry and behavioral neurology/treatment development and clinical trials. (7th December 2020)

Authors:
Majid, Tabassum; Paulsen, Russ; Callahan, Leigh F.; Potashman, Michele; Lee, Daniel; Hartry, Ann; Wunderlich, Glen; Hoffman, Deborah; Wieberg, Dan; Kremer, Ian N.; DiBenedetti, Dana B.
Journal:
Alzheimer's & dementia
Issue:
Volume 16(2020)Supplement 6
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗